Navigation Links
Latest drug shows promise in multiple myeloma

According to researchers, many trials show that a new type of drug can assist patients with multiple myeloma who have failed to respond to other treatments.// Multiple myeloma is an incurable cancer of the bone marrow. Researchers at Dana-Farber Cancer Institute have been assessing a new drug, called bortezomib, in a group of 180 patients who had not been helped by other forms of treatment. In the first sub-group, consisting of 65 patients, 30 per cent showed at least a partial response, with some showing a complete response, in which no sign of active disease could be detected.

In all, 78 per cent either had their condition either stabilize or improve from the start of the therapy, and some were still showing a positive response up to a year later. Bortezomib is a new kind of drug called a proteasome inhibitor. It acts on tiny structures called proteasomes within cells and so stops myeloma cells from multiplying.


'"/>




Page: 1

Related medicine news :

1. Latest device for identifying Melanomas
2. Latest discovery on Autism
3. Latest device for cardiac revival under test
4. Latest technique for asthma treatment
5. Latest Findings On The Deadly Disease - SARS
6. Latest Tumor Classification More Informative
7. The Latest Preventative Treatment Option for Prostate Cancer
8. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
9. A Latest Study Links Fish To Stroke
10. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
11. Lovers Latest Hang Outs – Railway Platform
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of Northeast ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:5/4/2016)... ... , ... May kicked off with Melanoma Monday , a multi-agency effort ... Turner is encouraging her patients, as well as residents all around Dallas, Cleburne, Irving, ... now and in the future. , The dermatology-specific awareness month ends with “Don’t Fry ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, dentist in ... office. Wisdom tooth removal, a common dental procedure, is performed for many adolescents and ... erupted, resulting in risks of complications. By providing wisdom tooth removal surgery at their ...
(Date:5/4/2016)... California (PRWEB) , ... May 04, 2016 , ... ... formulation of foundational nutrients that supports cellular and metabolic health. This synergistic combination ... 400 mg free-form curcumin, along with 150 mg of reduced glutathione and 200 ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Ischemic Stroke Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Ischemic Stroke Market and Competitive Landscape Highlights ... Stroke pipeline products, Acute Ischemic Stroke epidemiology, ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Actinic Keratosis ...  report to their offering.       ... Actinic Keratosis Market and Competitive Landscape Highlights ... pipeline products, Actinic Keratosis epidemiology, Actinic Keratosis ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
Breaking Medicine Technology: